日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Polypharmacology of S-1117, an Fc-fused IgG-selective degrading enzyme, for chronic treatment of autoantibody-mediated diseases

S-1117(一种Fc融合的IgG选择性降解酶)的多药理学作用,用于慢性治疗自身抗体介导的疾病

Sanmarco, Liliana M; Pellerin, Alex; Green, Tobias; Plasencia, Agustin; Anderson, Jordan M; Le, Nam; Newton, Andita; Chen, Jiyun; Ramello, Maria Cecilia; Peckner, Ryan; Manasson, Julia; Xing, Yi; Vital, Heather; Higginson-Scott, Nathan; Sundy, John S; Otipoby, Kevin L; Mascanfroni, Ivan D

Safety, pharmacokinetics, and pharmacodynamics of MK-6194, an IL-2 mutein designed to selectively activate regulatory T cells: single ascending dose and multiple ascending dose trial data.

MK-6194(一种旨在选择性激活调节性 T 细胞的 IL-2 突变体)的安全性、药代动力学和药效学:单次递增剂量和多次递增剂量试验数据

Scheid Johannes F, Cunningham-Bussel Kiki, Kim Nancy, Agarwal Shiuli, Nieddu Garrett, Cote Josee, Lemoine Lieselotte, Decaesteker Tatjana, Mendez Luis, Paul Erina, Love-Gregory Latisha, Contreras Alejandra Virginia, Zhao Xuemei, Franco-Dilone Lucia, Pang Ling, Baltus Gretchen A, Beaumont Maribel, Shah Ketal, Higginson-Scott Nathan, Kis-Toth Katalin, Otipoby Kevin L, Viney Joanne L, Sicard Eric, Rottey Sylvie, Sundy John S, Van Dyck Kristien, Laethem Tine, Larson Patrick, Sutradhar Santosh, Wnek Richard, Bueters Tjerk, Lai Eseng, Stoch S Aubrey, Iwamoto Marian, Robbins Jonathan A

Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial

在既往未接受过甲氨蝶呤治疗或接受过甲氨蝶呤治疗的活动性类风湿关节炎患者中,菲戈替尼联合甲氨蝶呤或单药治疗与甲氨蝶呤单药治疗的疗效比较:FINCH 3 期随机对照试验

Westhovens, René; Rigby, William F C; van der Heijde, Désirée; Ching, Daniel W T; Stohl, William; Kay, Jonathan; Chopra, Arvind; Bartok, Beatrix; Matzkies, Franziska; Yin, Zhaoyu; Guo, Ying; Tasset, Chantal; Sundy, John S; Jahreis, Angelika; Mozaffarian, Neelufar; Messina, Osvaldo Daniel; Landewé, Robert Bm; Atsumi, Tatsuya; Burmester, Gerd R

Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial

在对甲氨蝶呤反应不足的类风湿性关节炎患者中,菲戈替尼与安慰剂或阿达木单抗的疗效比较:一项 III 期随机临床试验

Combe, Bernard; Kivitz, Alan; Tanaka, Yoshiya; van der Heijde, Désirée; Simon, J Abraham; Baraf, Herbert S B; Kumar, Uma; Matzkies, Franziska; Bartok, Beatrix; Ye, Lei; Guo, Ying; Tasset, Chantal; Sundy, John S; Jahreis, Angelika; Genovese, Mark C; Mozaffarian, Neelufar; Landewé, Robert B M; Bae, Sang-Cheol; Keystone, Edward C; Nash, Peter

Effect of Filgotinib vs Placebo on Clinical Response in Patients With Moderate to Severe Rheumatoid Arthritis Refractory to Disease-Modifying Antirheumatic Drug Therapy: The FINCH 2 Randomized Clinical Trial

菲戈替尼与安慰剂对难治性中重度类风湿关节炎患者临床反应的影响:FINCH 2 随机临床试验

Genovese, Mark C; Kalunian, Kenneth; Gottenberg, Jacques-Eric; Mozaffarian, Neelufar; Bartok, Beatrix; Matzkies, Franziska; Gao, Jie; Guo, Ying; Tasset, Chantal; Sundy, John S; de Vlam, Kurt; Walker, David; Takeuchi, Tsutomu

Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis

重测序研究证实,宿主防御和细胞衰老基因变异与特发性肺纤维化风险相关

Moore, Camille; Blumhagen, Rachel Z; Yang, Ivana V; Walts, Avram; Powers, Julie; Walker, Tarik; Bishop, Makenna; Russell, Pamela; Vestal, Brian; Cardwell, Jonathan; Markin, Cheryl R; Mathai, Susan K; Schwarz, Marvin I; Steele, Mark P; Lee, Joyce; Brown, Kevin K; Loyd, James E; Crapo, James D; Silverman, Edwin K; Cho, Michael H; James, Judith A; Guthridge, Joel M; Cogan, Joy D; Kropski, Jonathan A; Swigris, Jeffrey J; Bair, Carol; Kim, Dong Soon; Ji, Wonjun; Kim, Hocheol; Song, Jin Woo; Maier, Lisa A; Pacheco, Karin A; Hirani, Nikhil; Poon, Azin S; Li, Feng; Jenkins, R Gisli; Braybrooke, Rebecca; Saini, Gauri; Maher, Toby M; Molyneaux, Philip L; Saunders, Peter; Zhang, Yingze; Gibson, Kevin F; Kass, Daniel J; Rojas, Mauricio; Sembrat, John; Wolters, Paul J; Collard, Harold R; Sundy, John S; O'Riordan, Thomas; Strek, Mary E; Noth, Imre; Ma, Shwu-Fan; Porteous, Mary K; Kreider, Maryl E; Patel, Namrata B; Inoue, Yoshikazu; Hirose, Masaki; Arai, Toru; Akagawa, Shinobu; Eickelberg, Oliver; Fernandez, Isis Enlil; Behr, Jürgen; Mogulkoc, Nesrin; Corte, Tamera J; Glaspole, Ian; Tomassetti, Sara; Ravaglia, Claudia; Poletti, Venerino; Crestani, Bruno; Borie, Raphael; Kannengiesser, Caroline; Parfrey, Helen; Fiddler, Christine; Rassl, Doris; Molina-Molina, Maria; Machahua, Carlos; Worboys, Ana Montes; Gudmundsson, Gunnar; Isaksson, Helgi J; Lederer, David J; Podolanczuk, Anna J; Montesi, Sydney B; Bendstrup, Elisabeth; Danchel, Vivi; Selman, Moises; Pardo, Annie; Henry, Michael T; Keane, Michael P; Doran, Peter; Vašáková, Martina; Sterclova, Martina; Ryerson, Christopher J; Wilcox, Pearce G; Okamoto, Tsukasa; Furusawa, Haruhiko; Miyazaki, Yasunari; Laurent, Geoffrey; Baltic, Svetlana; Prele, Cecilia; Moodley, Yuben; Shea, Barry S; Ohta, Ken; Suzukawa, Maho; Narumoto, Osamu; Nathan, Steven D; Venuto, Drew C; Woldehanna, Merte L; Kokturk, Nurdan; de Andrade, Joao A; Luckhardt, Tracy; Kulkarni, Tejaswini; Bonella, Francesco; Donnelly, Seamus C; McElroy, Aoife; Armstong, Michelle E; Aranda, Alvaro; Carbone, Roberto G; Puppo, Francesco; Beckman, Kenneth B; Nickerson, Deborah A; Fingerlin, Tasha E; Schwartz, David A

Effects of Selonsertib in Patients with Diabetic Kidney Disease

Selonsertib 对糖尿病肾病患者的影响

Chertow, Glenn M; Pergola, Pablo E; Chen, Fang; Kirby, Brian J; Sundy, John S; Patel, Uptal D

Andecaliximab [Anti-matrix Metalloproteinase-9] Induction Therapy for Ulcerative Colitis: A Randomised, Double-Blind, Placebo-Controlled, Phase 2/3 Study in Patients With Moderate to Severe Disease

安地卡利昔单抗(抗基质金属蛋白酶-9)诱导治疗溃疡性结肠炎:一项针对中重度溃疡性结肠炎患者的随机、双盲、安慰剂对照的II/III期研究

Sandborn, William J; Bhandari, Bal R; Randall, Charles; Younes, Ziad H; Romanczyk, Tomasz; Xin, Yan; Wendt, Emily; Chai, Hao; McKevitt, Matt; Zhao, Sally; Sundy, John S; Keshav, Satish; Danese, Silvio

A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn's Disease

一项评估基质金属蛋白酶-9抑制剂安德卡利昔单抗治疗中重度活动性克罗恩病患者的II期随机、安慰剂对照研究

Schreiber, Stefan; Siegel, Corey A; Friedenberg, Keith A; Younes, Ziad H; Seidler, Ursula; Bhandari, Bal R; Wang, Ke; Wendt, Emily; McKevitt, Matt; Zhao, Sally; Sundy, John S; Lee, Scott D; Loftus, Edward V

The cortisol:C-reactive protein ratio and negative affect reactivity in depressed adults

抑郁症成年人的皮质醇/C反应蛋白比值与负面情绪反应性

Suarez, Edward C; Sundy, John S